Steven Deeks

Credentials: · ·

History

Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Nature Medicine · 2006 · 2,870 citations
The end of AIDS: HIV infection as a chronic disease
Review · The Lancet · 2013 · First of 3 authors · Corresponding · 1,491 citations
HIV infection, inflammation, immunosenescence, and aging
Review · Annual Review of Medicine · 2011 · Sole author · 1,118 citations

MAATCH: Modeling Antibody Approaches for a Tailored Cure for HIV
National Institute of Allergy and Infectious Diseases · R01
PI · $1.7M · Henry m. Jackson Fdn for the Adv Mil/Med
2026–2031
A Phase 1/2a, Randomized Study of a Tfh-Targeting Genetic Vaccine Adjuvant Designed to Induce Broad, Durable Immune Responses
National Institute of Allergy and Infectious Diseases · U01
PI · $4.3M · University of California Los Angeles
2024–2029
Delaney AIDS Research Enterprise to Cure HIV
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $32M · University of California, San Francisco
2021–2028
UCSF-Bay Area Center for AIDS Research
National Institute of Allergy and Infectious Diseases · P30
Project lead · $4.4M · University of California, San Francisco
1997–2027

A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
Principal investigator · Recruiting · Phase 1, Phase 2
Kara Chew
2025–2029
CAR-T Cells for HIV Infection
Principal investigator · Recruiting · Phase 1, Phase 2
Steven Deeks
2021–2029
SCOPE Analytic Treatment Interruption Protocol
Principal investigator · Recruiting
University of California, San Francisco
2020–2028
Long-term Impact of Infection With Novel Coronavirus (COVID-19)
Principal investigator · Recruiting
University of California, San Francisco
2020–2030